Good morning, Plenty of deal news to bring you from across MedTech and biotech. My summary covers headlines from gene editing, respiratory diagnostics, neuroscience, and more. 🔔 Scribe Therapeutics has overshot its own expectations with an IPO that’s set to bring in…
Read More
Here is Matt Lowdon‘s weekly medtech, deeptech, and biotech funding summary. Headlines include updates across energy intel, AI DD, neurotech and more. 🔔 Dimerix Limited snaps up Mission Therapeutics’s phase 2-ready kidney disease candidate in $292M deal. 🔔 The British Business…
Read MoreBy continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.